TrialCancer immunology, immunotherapy : CII2012

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial.

Hilko Ardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.